Group One Trading, L.P. Adamis Pharmaceuticals Corp Transaction History

Group One Trading, L.P.

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$0.1 - $0.3 $560 - $1,682	5,609 New	5,609 $0
Q2 2021 Aug 10, 2021	SELL	$0.66 - $1.23 $58,367 - $108,775	-88,435 Closed	0 $0
Q1 2021 May 12, 2021	BUY	$0.54 - $1.79 $47,754 - $158,298	88,435 New	88,435 $83,000
Q3 2020 Nov 12, 2020	SELL	$0.52 - $1.45 $7,458 - $20,797	-14,343 Closed	0 $0
Q2 2020 Aug 13, 2020	SELL	$0.33 - $0.66 $1,707 - $3,414	-5,173 Reduced 26.51%	14,343 $8,000
Q1 2020 May 13, 2020	BUY	$0.33 - $0.89 $495 - $1,335	1,500 Added 8.33%	19,516 $7,000
Q4 2019 Feb 10, 2020	SELL	$0.51 - $1.26 $6,143 - $15,179	-12,047 Reduced 40.07%	18,016 $13,000
Q3 2019 Nov 12, 2019	SELL	$0.7 - $1.46 $23,632 - $49,289	-33,760 Reduced 52.9%	30,063 $21,000
Q2 2019 Aug 09, 2019	SELL	$1.26 - $2.23 $23,520 - $41,627	-18,667 Reduced 22.63%	63,823 $83,000
Q1 2019 May 13, 2019	BUY	$2.02 - $3.22 $30,673 - $48,895	15,185 Added 22.56%	82,490 $174,000
Q4 2018 Feb 06, 2019	SELL	$2.1 - $3.21 $20,687 - $31,621	-9,851 Reduced 12.77%	67,305 $151,000
Q3 2018 Nov 08, 2018	BUY	$2.25 - $4.8 $121,394 - $258,974	53,953 Added 232.53%	77,156 $270,000
Q2 2018 Aug 14, 2018	SELL	$3.2 - $4.7 $88,995 - $130,711	-27,811 Reduced 54.52%	23,203 $74,000
Q1 2018 May 11, 2018	SELL	$2.55 - $4.85 $7,938 - $15,098	-3,113 Reduced 5.75%	51,014 $179,000
Q4 2017 Feb 09, 2018	SELL	$3.5 - $5.65 $121,957 - $196,874	-34,845 Reduced 39.16%	54,127 $238,000
Q3 2017 Nov 15, 2017	SELL	$4.5 - $5.65 $62,694 - $78,715	-13,932 Reduced 13.54%	88,972 $465,000
Q2 2017 Aug 14, 2017	BUY	N/A	102,904	102,904 $535,000

Ticker ADMP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 149,983,008
Market Cap $73.5M
Description
Adamis Pharmaceuticals Corporation, a specialty biopharmaceutical company, develops and commercializes products in the therapeutic areas of allergy, opioid overdose, respiratory, and inflammatory disease in the United States. The company's product candidates comprise SYMJEPI epinephrine pre-filled syringe injectable products for use in the emerg...

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

Stay updated on Group One Trading, L.P. with notifications on news.